Tharimmune to Participate in Microcap Conference 2025

Tharimmune, Inc., a biotechnology company listed on Nasdaq (THAR), will be present at The Microcap Conference 2025. The event will take place from January 28 to 30 in Atlantic City, New Jersey. Management will present on January 30 at 10:00 AM Eastern Time at the Borgata Hotel Casino & Spa.

Tharimmune will engage in discussions with investors, focusing on recent developments and strategic growth. This provides an opportunity to showcase investment prospects. The company is focused on advancing therapies in the fields of immunology and inflammation.

Tharimmune is developing key assets like TH104, aimed at alleviating symptoms of rare autoimmune liver disease, and TH023, an oral inhibitor targeting autoimmune conditions. Investors can register for direct meetings through the conference's official portal.